Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Other Accumulated Expenses (2022 - 2025)

Acro Biomedical has reported Other Accumulated Expenses over the past 4 years, most recently at $1100.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $1100.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $1100.0 (changed 0.0% YoY), and the annual figure for FY2025 was $1100.0, changed 0.0%.
  • Other Accumulated Expenses for Q4 2025 was $1100.0 at Acro Biomedical, roughly flat from $1100.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for ACBM hit a ceiling of $79078.0 in Q3 2023 and a floor of $1100.0 in Q4 2023.
  • Median Other Accumulated Expenses over the past 4 years was $39963.0 (2022), compared with a mean of $40029.0.
  • Biggest five-year swings in Other Accumulated Expenses: plummeted 98.6% in 2023 and later changed 0.0% in 2024.
  • Acro Biomedical's Other Accumulated Expenses stood at $78826.0 in 2022, then plummeted by 98.6% to $1100.0 in 2023, then changed by 0.0% to $1100.0 in 2024, then changed by 0.0% to $1100.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $1100.0 (Q4 2025), $1100.0 (Q4 2024), and $1100.0 (Q4 2023) per Business Quant data.